Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Journal of Biopharmaceutical Statistics
|
October 22, 2013
Selection of hypothesis weights and ordering when testing multiple hypotheses in clinical trials
Brian L Wiens, Alex Dmitrienko, Olga Marchenko
Biometrical Journal. Biometrische Zeitschrift
|
October 22, 2008
General multistage gatekeeping procedures
Alex Dmitrienko, Ajit C Tamhane, Brian L Wiens
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Recent Statistical Contributions to Medical Device Development
Brian L Wiens, Theodore C Lystig, Scott M Berry
Statistics in Medicine
|
October 21, 2006
Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives
Alex Dmitrienko, Brian L Wiens, Ajit C Tamhane, et al.
Statistics in Medicine
|
May 20, 2008
A note on tree gatekeeping procedures in clinical trials
Alex Dmitrienko, Ajit C Tamhane, Lingyun Liu, et al.
The New England Journal of Medicine
|
May 28, 2016
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
Alexander T Cohen, Robert A Harrington, Samuel Z Goldhaber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2005
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study
Charles L Vogel, Marek Z Wojtukiewicz, Robert R Carroll, et al.
Lancet (London, England)
|
September 15, 2009
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
Michael A Weber, Henry Black, George Bakris, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
October 6, 2007
Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study
Henry R Black, George L Bakris, Michael A Weber, et al.
The New England Journal of Medicine
|
November 13, 2015
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
Deborah M Siegal, John T Curnutte, Stuart J Connolly, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Journal of Biopharmaceutical Statistics
|
October 22, 2013
Selection of hypothesis weights and ordering when testing multiple hypotheses in clinical trials
Brian L Wiens, Alex Dmitrienko, Olga Marchenko
Biometrical Journal. Biometrische Zeitschrift
|
October 22, 2008
General multistage gatekeeping procedures
Alex Dmitrienko, Ajit C Tamhane, Brian L Wiens
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Recent Statistical Contributions to Medical Device Development
Brian L Wiens, Theodore C Lystig, Scott M Berry
Statistics in Medicine
|
October 21, 2006
Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives
Alex Dmitrienko, Brian L Wiens, Ajit C Tamhane, et al.
Statistics in Medicine
|
May 20, 2008
A note on tree gatekeeping procedures in clinical trials
Alex Dmitrienko, Ajit C Tamhane, Lingyun Liu, et al.
The New England Journal of Medicine
|
May 28, 2016
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
Alexander T Cohen, Robert A Harrington, Samuel Z Goldhaber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 19, 2005
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study
Charles L Vogel, Marek Z Wojtukiewicz, Robert R Carroll, et al.
Lancet (London, England)
|
September 15, 2009
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
Michael A Weber, Henry Black, George Bakris, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
October 6, 2007
Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study
Henry R Black, George L Bakris, Michael A Weber, et al.
The New England Journal of Medicine
|
November 13, 2015
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
Deborah M Siegal, John T Curnutte, Stuart J Connolly, et al.
Page
of 3